Institutional Ownership
Protalix Biotherapeutics Inc
CUSIP 74365A309COMPLXQ1 2026
Institutional Holders
97
13F filers
Shares Held
16.15M
Aggregate institutional
Institutional Value
$34.72M
Q1 2026
Net New Holders
+18
26 new · 8 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions26
Increased27
Decreased20
Sold out8
Institutional Holders
97 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | 3.62M | $7.85M | −30.1K | Reduced |
| 2 | Mak Capital One LLC | 3.54M | $7.69M | +3.54M | New |
| 3 | Renaissance Technologies LLC | 1.22M | $2.66M | −38.5K | Reduced |
| 4 | State Street Corp | 972.8K | $2.11M | +387.6K | Added |
| 5 | Northern Trust Corp | 885.4K | $1.92M | +19.7K | Added |
| 6 | Geode Capital Management, LLC | 865.3K | $1.88M | +35.2K | Added |
| 7 | Stratos Wealth Partners, Ltd. | 500.0K | $1.08M | 0 | Held |
| 8 | Prospera Financial Services Inc | 418.6K | $908.3K | +418.6K | New |
| 9 | Opaleye Management Inc. | 340.0K | $737.8K | −2.14M | Reduced |
| 10 | Morgan Stanley | 301.8K | $654.9K | +169.8K | Added |
87 more institutional holders on Premium
See every fund holding Protalix Biotherapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders